Octyl 3,5-di-tert-butyl-4-hydroxybenzoate, 250mg

4-Bromo-2-nitrobenzoic acid, 97.0%, 100g

4,4'-(Ethane-1,2-diyl)bis(morpholine-2,6-dione), 95.0%, 500g

2-(4-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid, 95.0%, 250mg

Bottiglia sottovuoto tipo 2126, 4000 ml, 83 B, 1 pezzo

4-amino-2-chlorobenzamide, 95.0%, 5g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 100g

3-(4-ethylphenyl)-6-(piperazin-1-yl)pyridazine, 95.0%, 2g

4,4,5,5-Tetramethyl-2-(2-methyl-4-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane, 97%, 1g

tert-Butyl 3-hydroxy-3-(trifluoromethyl)azetidine-1-carboxylate, 95.0%, 1g

3-Phenylazo-2,6-diaminopyridine hydrochloride, 95.0%, 100g

tert-Butyl ((3S,4R)-3-aminotetrahydro-2H-pyran-4-yl)carbamate, 97%, 100mg

3-METHYL-5-NITRO-1H-PYRAZOLO[3,4-B]PYRIDINE, 95%, 100mg